The primary objective of Pharmaceutical Trade Marks Group (PTMG) is to enable members to meet at regular intervals to consider problems of mutual interest. It does this by running educational conferences relating to the law and practice of trade marks and other intellectual property particularly as they affect pharmaceutical and related industries. UnitedLex Lead IP Adviser, Sophie Bodet, is attending their Autumn conference.
Trade marks are an important source of orientation for both patients and healthcare professionals in the pharmaceutical market, with its confusing multitude of products. Not only are they valuable marketing instruments of pharmaceutical companies, but they also help to avoid name related medication errors, thus increasing patient safety.